Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2005-11-16 15:48:42 UTC
Update Date2022-03-07 02:49:02 UTC
HMDB IDHMDB0000412
Secondary Accession Numbers
  • HMDB00412
Metabolite Identification
Common Name3beta,17alpha-Dihydroxy-5alpha-androstane
Description3beta,17alpha-Dihydroxy-5alpha-androstane is a steroid found in the monosulfate fraction of normal human feces. Several steroids identified in the disulfate fraction of human bile are found in the monosulfate fraction of human feces, indicating partial hydrolysis of diconjugates in the intestine. The androstanediols and pregnanediols found in the feces are primarily of a 3beta-hydroxy-5alpha- or 3beta-hydroxy-5beta-structure, whereas those in the bile are of a 3alpha-hydroxy-5alpha- or 3alpha-hydroxy-5beta-structure. This suggests the conversion of a 3alpha-hydroxyl to a 3beta-hydroxyl in the intestine in vivo. 3beta,17alpha-Dihydroxy-5alpha-androstane is also found unconjugated in normal human plasma (PMID: 4245755 , 4223807 , 4321841 , 1769135 ).
Structure
Data?1582752130
Synonyms
ValueSource
5-ALPHA-ANDROSTANE-3-BETA,17-ALPHA-diolChEBI
5-a-ANDROSTANE-3-b,17-a-diolGenerator
5-Α-androstane-3-β,17-α-diolGenerator
3b,17a-Dihydroxy-5a-androstaneGenerator
3Β,17α-dihydroxy-5α-androstaneGenerator
5 Androstane 3,17 diolHMDB
5 alpha Androstane 3 alpha,17 beta diolHMDB
5 alpha Androstane 3 beta,17 alpha diolHMDB
5 alpha Androstane 3 beta,17 beta diolHMDB
5 alpha Androstane 3alpha,17 beta diolHMDB
5 alpha-Androstane-3 alpha,17 beta-diolHMDB
5 alpha-Androstane-3 beta,17 alpha-diolHMDB
5 alpha-Androstane-3 beta,17 beta-diolHMDB
5 alpha-Androstane-3alpha,17 beta-diolHMDB
5 beta Androstane 3 alpha,17 beta diolHMDB
5 beta-Androstane-3 alpha,17 beta-diolHMDB
5-Androstane-3,17-diolHMDB
5alpha Androstane 3beta,17alpha diolHMDB
5alpha-Androstane-3beta,17alpha-diolHMDB
Androstane 3,17 diolHMDB
Androstane-3,17-diolHMDB
5a-Androstane-3b,17a-diolHMDB
5Α-androstane-3β,17α-diolHMDB
(3beta,5alpha,17alpha)-Androstane-3,17-diolHMDB
(3Β,5α,17α)-androstane-3,17-diolHMDB
5alpha-Androstan-3beta,17alpha-diolHMDB
5Α-androstan-3β,17α-diolHMDB
3beta,17alpha-Dihydroxy-5alpha-androstaneHMDB
Chemical FormulaC19H32O2
Average Molecular Weight292.4562
Monoisotopic Molecular Weight292.240230268
IUPAC Name(1S,2S,5S,7S,10R,11S,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol
Traditional Name(1S,2S,5S,7S,10R,11S,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol
CAS Registry Number5856-11-1
SMILES
[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C
InChI Identifier
InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17+,18-,19-/m0/s1
InChI KeyCBMYJHIOYJEBSB-MFXFBURESA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassAndrostane steroids
Direct ParentAndrogens and derivatives
Alternative Parents
Substituents
  • Androgen-skeleton
  • 17-hydroxysteroid
  • 3-beta-hydroxysteroid
  • Hydroxysteroid
  • 3-hydroxysteroid
  • Cyclic alcohol
  • Secondary alcohol
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organooxygen compound
  • Alcohol
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.019 g/LALOGPS
logP3.56ALOGPS
logP3.2ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)18.3ChemAxon
pKa (Strongest Basic)-0.76ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area40.46 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity84.63 m³·mol⁻¹ChemAxon
Polarizability35.45 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-206.65830932474
DeepCCS[M+Na]+181.09330932474
AllCCS[M+H]+177.232859911
AllCCS[M+H-H2O]+174.332859911
AllCCS[M+NH4]+180.032859911
AllCCS[M+Na]+180.732859911
AllCCS[M-H]-179.132859911
AllCCS[M+Na-2H]-179.432859911
AllCCS[M+HCOO]-179.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
3beta,17alpha-Dihydroxy-5alpha-androstane[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C2433.3Standard polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C2438.1Standard non polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C2611.3Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
3beta,17alpha-Dihydroxy-5alpha-androstane,1TMS,isomer #1C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@H]2O[Si](C)(C)C2563.9Semi standard non polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane,1TMS,isomer #2C[C@]12CC[C@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@H]2O2552.9Semi standard non polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane,2TMS,isomer #1C[C@]12CC[C@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@H]2O[Si](C)(C)C2573.3Semi standard non polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)O[C@@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C2857.1Semi standard non polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@H]2O)C12820.7Semi standard non polar33892256
3beta,17alpha-Dihydroxy-5alpha-androstane,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@H]2O[Si](C)(C)C(C)(C)C)C13133.6Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TBDMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Positive-QTOFsplash10-004l-0090000000-22d60c19836ea8b4c2912017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Positive-QTOFsplash10-056r-0390000000-edb0fb77b27575b4b7292017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Positive-QTOFsplash10-00mk-2980000000-cd6eafa93f3164ed780a2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Negative-QTOFsplash10-0006-0090000000-bc689c3cdfdf044c011e2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Negative-QTOFsplash10-006x-0090000000-bfbc140857bbdb62bcff2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Negative-QTOFsplash10-06vm-1290000000-bced1e06a8686f3501af2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Negative-QTOFsplash10-0006-0090000000-11452f48ce72555f1f282021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Negative-QTOFsplash10-0006-0090000000-11452f48ce72555f1f282021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Negative-QTOFsplash10-000l-0090000000-ac9e93370094e8aebfa12021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Positive-QTOFsplash10-002f-0090000000-36f4d97265b0d994d6282021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Positive-QTOFsplash10-052b-3940000000-b87bad8b672cc5fb32b02021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Positive-QTOFsplash10-0aos-3900000000-0f8ce10c286f165d6e0f2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
  • Extracellular
  • Membrane
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB03926
Phenol Explorer Compound IDNot Available
FooDB IDFDB111637
KNApSAcK IDNot Available
Chemspider ID394165
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN ID5401
PubChem Compound446934
PDB IDNot Available
ChEBI ID40836
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceHan, Guang-Dian; Lin, Zi-Yun; Yan, Chong-Ping. Synthesis of musk androgen 5a-androstane-3b,17a-diol. Zhongguo Yiyao Gongye Zazhi (1994), 25(11), 490-1.
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Laatikainen T, Vihko R: Identification of C19O2 and C21O2 steroids in the mono- and disulphate fractions of human faeces. Eur J Biochem. 1970 Apr;13(3):534-8. [PubMed:4245755 ]
  2. Vihko R: Gas chromatographic-mass spectrometric studies on solvolyzable steroids in human peripheral plasma. Acta Endocrinol (Copenh). 1966;52:Suppl 109:1-67. [PubMed:4223807 ]
  3. Laatikainen T, Vihko R: Unconjugated C19 and C21 steroids in human faeces. Ann Clin Res. 1970 Dec;2(4):350-3. [PubMed:4321841 ]
  4. Stillman SC, Evans BA, Hughes IA: Androgen dependent stimulation of aromatase activity in genital skin fibroblasts from normals and patients with androgen insensitivity. Clin Endocrinol (Oxf). 1991 Dec;35(6):533-8. [PubMed:1769135 ]